AAAAAA

   
Results: 1-8 |
Results: 8
COST-EFFECTIVENESS ANALYSIS COMPARING LIPOSOMAL ANTHRACYCLINES IN THETREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA
Authors: BENNETT CL GOLUB RM STINSON TJ ABOULAFIA DM VONROENN J BOGNER J GOEBEL FD STEWART S
Citation: Cl. Bennett et al., COST-EFFECTIVENESS ANALYSIS COMPARING LIPOSOMAL ANTHRACYCLINES IN THETREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA, Journal of acquired immune deficiency syndromes and human retrovirology, 18(5), 1998, pp. 460-465
KAPOSIS-SARCOMA RESPONSE CRITERIA - ISSUES IDENTIFIED BY THE NATIONAL-CANCER-INSTITUTE, FOOD-AND-DRUG-ADMINISTRATION, AND THE AIDS-MALIGNANCY-CONSORTIUM
Authors: FEIGAL EG VONROENN J JUSTICE R YARCHOAN R KROWN S PLUDA J ARBUCK S MURGO A MCCABE M UNGERLEIDER R WITTES R
Citation: Eg. Feigal et al., KAPOSIS-SARCOMA RESPONSE CRITERIA - ISSUES IDENTIFIED BY THE NATIONAL-CANCER-INSTITUTE, FOOD-AND-DRUG-ADMINISTRATION, AND THE AIDS-MALIGNANCY-CONSORTIUM, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 24-24
THERAPEUTIC OPTIONS FOR HIV-ASSOCIATED BODYWEIGHT LOSS - A RISK-BENEFIT ANALYSIS
Authors: STOSOR V VONROENN J
Citation: V. Stosor et J. Vonroenn, THERAPEUTIC OPTIONS FOR HIV-ASSOCIATED BODYWEIGHT LOSS - A RISK-BENEFIT ANALYSIS, Drug safety, 17(5), 1997, pp. 290-302
LOW-DOSE COMPARED WITH STANDARD-DOSE M-BACOD CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: KAPLAN LD STRAUS DJ TESTA MA VONROENN J DEZUBE BJ COOLEY TP HERNDIER B NORTHFELT DW HUANG J TULPULE A LEVINE AM
Citation: Ld. Kaplan et al., LOW-DOSE COMPARED WITH STANDARD-DOSE M-BACOD CHEMOTHERAPY FOR NON-HODGKINS-LYMPHOMA ASSOCIATED WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 336(23), 1997, pp. 1641-1648
HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND SUBSEQUENT MELANOMA
Authors: KIND GM VONROENN J JANSEN DA BAILEY MH LEWIS VL
Citation: Gm. Kind et al., HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND SUBSEQUENT MELANOMA, Annals of plastic surgery, 37(3), 1996, pp. 273-277
THE BRISTOL-MYERS ANOREXIA CACHEXIA RECOVERY INSTRUMENT (BACRI) - A BRIEF ASSESSMENT OF PATIENTS SUBJECTIVE RESPONSE TO TREATMENT FOR ANOREXIA CACHEXIA
Authors: CELLA DF VONROENN J LLOYD S BROWDER HP
Citation: Df. Cella et al., THE BRISTOL-MYERS ANOREXIA CACHEXIA RECOVERY INSTRUMENT (BACRI) - A BRIEF ASSESSMENT OF PATIENTS SUBJECTIVE RESPONSE TO TREATMENT FOR ANOREXIA CACHEXIA, Quality of life research, 4(3), 1995, pp. 221-231
HAND-FOOT SYNDROME-ASSOCIATED WITH LIPOSOME-ENCAPSULATED DOXORUBICIN THERAPY
Authors: GORDON KB TAJUDDIN A GUITART J KUZEL TM ERAMO LR VONROENN J
Citation: Kb. Gordon et al., HAND-FOOT SYNDROME-ASSOCIATED WITH LIPOSOME-ENCAPSULATED DOXORUBICIN THERAPY, Cancer, 75(8), 1995, pp. 2169-2173
EPIDEMIOLOGIC ANALYSIS OF KAPOSI-SARCOMA AS AN EARLY AND LATER AIDS OUTCOME IN HOMOSEXUAL MEN
Authors: HOOVER DR BLACK C JACOBSON LP MARTINEZMAZA O SEMINARA D SAAH A VONROENN J ANDERSON R ARMENIAN HK
Citation: Dr. Hoover et al., EPIDEMIOLOGIC ANALYSIS OF KAPOSI-SARCOMA AS AN EARLY AND LATER AIDS OUTCOME IN HOMOSEXUAL MEN, American journal of epidemiology, 138(4), 1993, pp. 266-278
Risultati: 1-8 |